
Bivalirudin for Treatment of Aortic Valve Thrombosis After Left Ventricular Assist Device Implantation
Author(s) -
Sinan Sarsam,
Andrew B. Civitello,
Enoch Agunanne,
Reynolds M. Delgado
Publication year - 2013
Publication title -
asaio journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 66
eISSN - 1538-943X
pISSN - 1058-2916
DOI - 10.1097/mat.0b013e3182937a65
Subject(s) - bivalirudin , medicine , cardiology , ventricular assist device , thrombosis , heart failure , aortic valve , population , surgery , percutaneous coronary intervention , myocardial infarction , environmental health
Ventricular assist devices are increasingly being used for mechanical support in patients with advanced heart failure. However, thromboembolism remains a leading cause of mortality in this population. We describe the successful treatment of native aortic valve thrombosis with bivalirudin in a patient with factor V Leiden mutation, who had undergone left ventricular assist device implantation, preventing the need for further surgical intervention.